Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Significance of Cystic Biliary Dilatation in Primary Sclerosing Cholangitis.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026
Same author

Natural Course of Asymptomatic Walled-off Necrosis due to Acute Pancreatitis.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026
Same author

Natural Course of Asymptomatic Walled-off Necrosis due to Acute Pancreatitis.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026
Same author

Endoscopic Transpapillary Gallbladder Drainage Reduces the Frequency of Biliopancreatic Events in the Waiting Period for Surgery, Even in Patients without Comorbid Diseases.

Digestion·2026
Same author

The challenge of cholecystectomy after successful choledocholithiasis extraction in elderly patients with comorbidities.

BMC surgery·2025
Same author

Combined endoscopic-percutaneous approach for magnetic compression anastomosis in post-transplant anastomotic biliary strictures.

European radiology·2025

Related Experiment Video

Updated: May 29, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

Extension of ulcerative colitis.

Canan Alkim1, Hüseyin Alkim, Ulkü Dağli

  • 1Şişli Etfal Training and Research Hospital, Department of Gastroenterology, İstanbul, Turkey. alkimca@hotmail.com

The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|September 28, 2011
PubMed
Summary

Ulcerative proctitis can extend to other colon segments. Patients with proctitis require regular follow-up and treatment, similar to those with more extensive ulcerative colitis, to manage disease progression.

More Related Videos

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
04:05

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

Related Experiment Videos

Last Updated: May 29, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
04:05

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease Research
  • Colorectal Health

Background:

  • Ulcerative proctitis is often underestimated regarding follow-up and treatment importance.
  • Disease extension from the rectum to proximal segments is a known but often overlooked phenomenon.

Purpose of the Study:

  • To evaluate the extension of ulcerative colitis cases initially limited to the rectum.
  • To compare rectal-limited cases with rectosigmoid and left-sided ulcerative colitis.
  • To identify features, risk factors, and the natural course of disease extension.

Main Methods:

  • Retrospective analysis of 193 ulcerative colitis patients.
  • Categorization into rectal (n=62), rectosigmoid (n=49), and left-sided (n=82) colitis groups.
  • Assessment of disease extension over a mean follow-up of 3.9 years.

Main Results:

  • 14% of patients experienced extension to proximal segments.
  • Extension rates were 16.1% for proctitis, 12.2% for rectosigmoiditis, and 13.4% for left-sided colitis.
  • Chronic active disease, amoebic attacks, steroid treatment, and lack of treatment increased extension risk (OR 2.79).

Conclusions:

  • Ulcerative proctitis requires the same regular treatment and follow-up as more extensive colitis.
  • Early detection and management of proctitis can potentially mitigate disease extension.
  • Risk stratification for extension is crucial for optimizing patient care.